Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ishita Drugs And IndustriesBOM:524400 +1.00%73 Median PS Value is ₹46.25 as of Jul. 21, 2026, which is 100% below its 10-year median of 1.61. GuruFocus rates BOM:524400 with a GF Score™ of 73/100 and a GF Value™ of ₹78.36 (Fairly Valued). The stock has 3 warning signs investors should review. Among 544 Drug Manufacturers companies, Ishita Drugs And Industries ranks worse than 84.74% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Ishita Drugs And Industries's Median PS Value or its related term are showing as below:
BOM:524400'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.94 Med: 1.61 Max: 1.86
Current: 1.55
During the past 13 years, the highest Price to Median PS Value of Ishita Drugs And Industries was 1.86. The lowest was 0.94. And the median was 1.61.
BOM:524400's Price-to-Median-PS-Value is ranked worse than 84.74% of 544
companies
in the Drug Manufacturers industry
Industry Median: 0.86
vs BOM:524400: 1.55
Ishita Drugs And Industries (BOM:524400) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Ishita Drugs And Industries's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
71.79
/
46.25
=
1.55
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ishita Drugs And Industries Median PS Value Related Terms
Ishita Drugs And Industries Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524400 vs ZTS, UTHR: Median PS Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ishita Drugs And Industries's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ishita Drugs And Industries Price-to-Median-PS-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ishita Drugs And Industries's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Ishita Drugs And Industries's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.9444.
Ishita Drugs And Industries's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹48.972.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ishita Drugs And Industries (BOM:524400) has a Median PS Value of ₹46.25 as of Jul. 21, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Ishita Drugs And Industries and its competitors. This is 2773% above median its historical median of 1.61. Over the past decade, Ishita Drugs And Industries' Median PS Value has ranged from 0.94 to 1.86. According to the industry distribution chart, Ishita Drugs And Industries ranks #461 out of 544 companies in the Drug Manufacturers industry, placing it in the top 84.7%.
Is Ishita Drugs And Industries' Median PS Value too high?
Ishita Drugs And Industries' current Median PS Value of ₹46.25 is 2773% above median its 10-year median of 1.61. Over the past 10 years, this metric has ranged from a low of 0.94 to a high of 1.86. Based on the distribution chart, Ishita Drugs And Industries ranks #461 out of 544 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Ishita Drugs And Industries has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ishita Drugs And Industries' Median PS Value compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ishita Drugs And Industries ranks #461 out of 544 companies for Median PS Value. This places Ishita Drugs And Industries in the lower half of its industry. The industry median Median PS Value is 0.86. Historically, Ishita Drugs And Industries' own Median PS Value has ranged from 0.94 to 1.86 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.86, based on 544 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Ishita Drugs And Industries and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ishita Drugs And Industries's current Median PS Value is ₹46.25, which is 2773% above median its own 10-year median of 1.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ishita Drugs And Industries stock overvalued right now?
Based on GuruFocus' analysis, Ishita Drugs And Industries (BOM:524400) is currently considered Fairly Valued. The stock's GF Value™ is ₹78.36, compared to a current price of ₹71.79 — trading 8.4% below its estimated fair value. The current Median PS Value is ₹46.25, which is 2773% above median its 10-year median of 1.61. Ishita Drugs And Industries' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Ishita Drugs And Industries (BOM:524400), the current Median PS Value is ₹46.25 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ishita Drugs And Industries (BOM:524400) Overvalued in 2026?
Based on GuruFocus' analysis, Ishita Drugs And Industries stock appears to be undervalued.
The current stock price of ₹71.79 is trading 8.4% below its estimated GF Value™ of ₹78.36.
GuruFocus considers Ishita Drugs And Industries to be Fairly Valued.
Key valuation signals for BOM:524400:
Median PS Value: ₹46.25 (2773% above median its 10-year median of 1.61)
GF Value™: ₹78.36 vs. price of ₹71.79 (8.4% below fair value)
No single metric tells the full story. See the BOM:524400 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ishita Drugs And Industries Ltd is engaged in the business of manufacturing various APIs and drug intermediates. The company supplies its products to various pharmaceutical companies and is also being exported to various countries across the world. The company has three manufacturing facilities located in the state of Gujarat, two for APIs and drug intermediates at Ahmedabad and Surendranagar, and one for finished pharmaceutical formulations at Mehsana.
73GF Score
Get the complete analysis for BOM:524400
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524400 has been successfully added to your 
